StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical total assets

Total assets on the balance sheet at the end of each period.

Rockwell Medical's total assets was $56.53M at Jun 30, 2026. For fiscal 2025 it was $57.15M, down 3.5% from the year before. Over ten years it grew -4.2% a year on average. The highest annual figure on record is $98.00M in fiscal 2014.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$57.15M-3.5%
FY2024Dec 31, 2024$59.21M+13.5%
FY2023Dec 31, 2023$52.17M+11.9%
FY2022Dec 31, 2022$46.64M-4.0%
FY2021Dec 31, 2021$48.57M-37.5%
FY2020Dec 31, 2020$77.75M+75.4%
FY2019Dec 31, 2019$44.32M-15.7%
FY2018Dec 31, 2018$52.56M-10.6%
FY2017Dec 31, 2017$58.78M-29.3%
FY2016Dec 31, 2016$83.15M-5.3%
FY2015Dec 31, 2015$87.82M-10.4%
FY2014Dec 31, 2014$98.00M+169.5%
FY2013Dec 31, 2013$36.36M+113.6%
FY2012Dec 31, 2012$17.03M-46.7%
FY2011Dec 31, 2011$31.94M-13.6%
FY2010Dec 31, 2010$36.97M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$56.53M+7.4%
Q1 FY2026Mar 31, 2026$57.42M+6.4%
Q4 FY2025Dec 31, 2025$57.15M-3.5%
Q3 FY2025Sep 30, 2025$57.49M+0.7%
Q2 FY2025Jun 30, 2025$52.63M-0.8%
Q1 FY2025Mar 31, 2025$53.96M+6.4%
Q4 FY2024Dec 31, 2024$59.21M+13.5%
Q3 FY2024Sep 30, 2024$57.08M+8.5%
Q2 FY2024Jun 30, 2024$53.03M+39.4%
Q1 FY2024Mar 31, 2024$50.72M+25.3%
Q4 FY2023Dec 31, 2023$52.17M+11.9%
Q3 FY2023Sep 30, 2023$52.61M-2.9%
Q2 FY2023Jun 30, 2023$38.04M-35.7%
Q1 FY2023Mar 31, 2023$40.47M+8.1%
Q4 FY2022Dec 31, 2022$46.64M-4.0%
Q3 FY2022Sep 30, 2022$54.19M-7.7%
Q2 FY2022Jun 30, 2022$59.12M-7.2%
Q1 FY2022Mar 31, 2022$37.44M-46.1%
Q4 FY2021Dec 31, 2021$48.57M-37.5%
Q3 FY2021Sep 30, 2021$58.70M-31.1%
Q2 FY2021Jun 30, 2021$63.68M+8.7%
Q1 FY2021Mar 31, 2021$69.45M+3.9%
Q4 FY2020Dec 31, 2020$77.75M+75.4%
Q3 FY2020Sep 30, 2020$85.24M+77.3%
Q2 FY2020Jun 30, 2020$58.58M+2.6%
Q1 FY2020Mar 31, 2020$66.83M+37.1%
Q4 FY2019Dec 31, 2019$44.32M-15.7%
Q3 FY2019Sep 30, 2019$48.09M+26.3%
Q2 FY2019Jun 30, 2019$57.08M+37.8%
Q1 FY2019Mar 31, 2019$48.75M-4.8%
Q4 FY2018Dec 31, 2018$52.56M-10.6%
Q3 FY2018Sep 30, 2018$38.08M-42.1%
Q2 FY2018Jun 30, 2018$41.42M-40.4%
Q1 FY2018Mar 31, 2018$51.21M-36.4%
Q4 FY2017Dec 31, 2017$58.78M-29.3%
Q3 FY2017Sep 30, 2017$65.81M-20.6%
Q2 FY2017Jun 30, 2017$69.48M–
Q1 FY2017Mar 31, 2017$80.46M–
Q4 FY2016Dec 31, 2016$83.15M–
Q3 FY2016Sep 30, 2016$82.85M–

More Rockwell Medical figures

See a number that looks wrong?